Results 211 to 220 of about 172,692 (301)

Best practice guidelines for the diagnosis, evaluation, and management of cognitive disorders in Parkinson's disease. [PDF]

Age Ageing
Pourzinal D, Brooks D, Sriram D, Mccann E, King JM, Pachana NA, Shrubsole K, Wood B, Lehn A, Marsh R, Liddle J, Mitchell LK, O'Sullivan JD, Tan ECK, Page N, Lobo EH, Verreynne ML, Lenzen S, Dissanayaka N.   +18 more
europepmc   +1 more source

Epileptic encephalopathy with spike‐and‐wave activation in sleep associated with Tatton–Brown–Rahman syndrome responsive to highly purified cannabidiol

Epileptic Disorders, EarlyView.
Anita N. Datta
wiley   +1 more source

Dynamic patterns of verbal memory function after an initial decline following temporal lobe resection against epilepsy: Sex‐specific differences in the postoperative course

Epilepsia, EarlyView.
Abstract Objective This study was performed to investigate the postoperative dynamics of verbal memory function after temporal lobe resection (TLR) in people with temporal lobe epilepsy (PwTLE), with a specific focus on the course following an initial verbal memory decline and the factors influencing later changes.
Pia Langenberg, Lea M. Reisch, Johanna L. Hopf, Florian J. Mücke, Lea Wemheuer, Christian G. Bien, Philip Grewe   +6 more
wiley   +1 more source

Epilepsia partialis continua as the presenting manifestation of Creutzfeldt–Jakob disease: A video‐polygraphic clinical vignette

Epileptic Disorders, EarlyView.
Roberta Cutellè, Angelo Pascarella, Ada Santoro, Vittoria Cianci, Anna Mammì, Giovanbattista Gaspare Tripodi, Caterina Prestandrea, Sara Gasparini, Edoardo Ferlazzo   +8 more
wiley   +1 more source

Evolution of the European Medicines Agency clinical guidelines for epilepsy drug development between 2010 and 2025: A comparative analysis by the ILAE Task Force on Regulatory Affairs

Epilepsia, EarlyView.
Abstract Objective The latest European Medicines Agency (EMA) guideline on the clinical investigation of medicines to treat epileptic disorders was adopted by the EMA Committee for Medicinal Products for Human Use in 2025. We compared this guideline with the previous version (2010), highlighting areas where significant revisions were introduced ...
Stéphane Auvin, Alexis Arzimanoglou, Jacqueline French, Kelly G. Knupp, Lieven Lagae, Eugen Trinka, Dennis Dlugos, Emilio Perucca   +7 more
wiley   +1 more source

Editorial: Reviews in neuropsychology

Frontiers in Psychology
María Jesús Luque-Rojas, Sara Palermo, Sara Palermo   +2 more
doaj   +1 more source

Comments on Beyond Seizure Control: A Case Series on Levetiracetam Associated Psychiatric Manifestations. [PDF]

Indian J Psychol Med
Finsterer J.
europepmc   +1 more source

Response to: Translational considerations in epilepsy surgery: Linking longitudinal cognitive phenotyping with epigenetic hypotheses

Epileptic Disorders, EarlyView.
Mary Lou Smith
wiley   +1 more source